Gastropleural fistula in a patient with recurrent ovarian cancer receiving combination therapy with Carboplatin, gemcitabine, and bevacizumab

J Clin Oncol. 2013 Apr 20;31(12):e208-10. doi: 10.1200/JCO.2012.45.1708. Epub 2013 Mar 18.

Authors

Thorsten Dohrmann¹, Asad Kutup, Sven Mahner, Volkmar Müller, Fritz Jaenicke, Jacob R Izbicki, Yogesh K Vashist

Affiliation

¹ University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

PMID: 23509305
DOI: 10.1200/JCO.2012.45.1708

No abstract available

Publication types

Case Reports

MeSH terms

Antibodies, Monoclonal, Humanized / administration & dosage
Antineoplastic Combined Chemotherapy Protocols / adverse effects*
Bevacizumab
Carboplatin / administration & dosage
Carcinoma, Ovarian Epithelial
Deoxycytidine / administration & dosage
Deoxycytidine / analogs & derivatives
Female
Gastric Fistula / chemically induced*
Gastric Fistula / pathology
Gastric Fistula / surgery
Gemcitabine
Humans
Intestinal Fistula / chemically induced*
Intestinal Fistula / pathology
Intestinal Fistula / surgery
Middle Aged
Neoplasm Recurrence, Local / drug therapy*
Neoplasm Recurrence, Local / pathology
Neoplasms, Glandular and Epithelial / complications
Neoplasms, Glandular and Epithelial / drug therapy*
Ovarian Neoplasms / complications
Ovarian Neoplasms / drug therapy*

Substances

Antibodies, Monoclonal, Humanized
Deoxycytidine
Bevacizumab
Carboplatin
Gemcitabine